Complex link between gut microbiome and immunotherapy response in advanced melanomaMarch 8, 2022MelanomaDermatologyOncologyMixed TopicsHematologic Malignancies
High early recurrence rates with Merkel cell carcinomaMarch 3, 2022Rare DiseasesMelanomaDermatologyOncologyCancer
Why dermatologists should support artificial intelligence effortsFebruary 24, 2022MelanomaBusiness of MedicineDermatology
“I didn’t want to meet you.” Dispelling myths about palliative careFebruary 2, 2022Mixed TopicsGenitourinary CancerLung CancerMelanomaOncologyCancer
Pioneering test predicts return of malignant melanomaJanuary 20, 2022MelanomaDermatologyOncologyCancer
U.S. cancer deaths continue to fall, especially lung cancerJanuary 13, 2022OncologyBreast CancerWomen's HealthMelanomaLung CancerCancer
High-fiber diet may improve melanoma immunotherapy response, outcomesDecember 28, 2021MelanomaDermatologyOncologyCancer
FDA expands pembrolizumab approval for advanced melanomaDecember 8, 2021MelanomaDermatologyOncologyCancer
‘Highest survival’ with combo immunotherapy in advanced melanomaDecember 7, 2021MelanomaDermatologyOncology
AI: Skin of color underrepresented in datasets used to identify skin cancerNovember 16, 2021MelanomaDermatologyOncology
Skin checks reduce all-cause but not melanoma-specific deathsNovember 3, 2021MelanomaDermatologyOncologyCancer
Sunscreen, other sun-protective habits not linked with poorer bone health, fracturesOctober 29, 2021Mixed TopicsMelanomaDermatology
Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomesOctober 28, 2021Lung CancerOncologyBreast CancerGenitourinary CancerMelanomaCancerMental Health
Many patients, doctors unaware of advancements in cancer careOctober 4, 2021Mixed TopicsOncologyBreast CancerGenitourinary CancerLung CancerMelanomaCancer
